Select Session

Emerging Strategies for Optimizing Outcomes in High Risk ACS: A Look at Where We’ve Been and What the Frontier Looks Like—From Anticoagulation to Stent Selection
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI - Program Chairman

The Evolution of Anticoagulation-Based Interventions in PCI: From UFH and LMWH to Direct Thrombin and Factor Xa Inhibition—What Have the Trials Taught Us? Where Will the New Breakthroughs Come?
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI - Program Chairman

Radial vs Femoral Access for PCI in the Setting of NSTE-ACS: Implications for Anticoagulation Management—Does Mode of Access Matter?
Sunil V. Rao MD, FACC FSCAI

Novel Anticoagulants for High Risk ACS: Rationale and Study Designs Focused on the Safety and Efficacy of Factor Xa Inhibition in the Setting of NSTE-ACS
David P. Faxon, MD

Contemporary and Evolving Approaches to Optimizing Outcomes in High Risk ACS: A Near Future Vision Statement Focused on Advances in Anticoagulation
Gregg W. Stone MD

Question and Answer
Faculty Panel